Population
Pregnant women with pulmonary arterial hypertension (PAH)
Design
Review
Key result
Targeted pulmonary vasodilators, including epoprostenol, iloprost, and sildenafil, are viable treatment options for pregnant patients with pulmonary arterial hypertension.
Authors
Loading...
May support targeted vasodilators in pregnant PAH; leaves open need for prospective trials to guide practice.
Targeted pulmonary vasodilators and low-molecular-weight heparin are viable and necessary treatment options for managing pulmonary arterial hypertension during pregnancy.
Huang et al. (2007) conducted a review in Pulmonary arterial hypertension in pregnancy. Targeted pulmonary vasodilators (epoprostenol, iloprost, sildenafil) was evaluated. Targeted pulmonary vasodilators, including epoprostenol, iloprost, and sildenafil, are viable treatment options for pregnant patients with pulmonary arterial hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: